Effect and safety of pemafibrate for patients with type 2 diabetes mellitus and hypertriglyceridemia: a retrospective analysis of clinical data

Abstract Objectives Fibrates are suitable for the treatment of patients with high triglyceride (TG) levels. Although pemafibrate (PEMA) has been reported to have beneficial and pleiotropic actions, clinical examinations of the efficacy of PEMA for Japanese patients with hypertriglyceridemia are stil...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Aki Okamoto, Hirohide Yokokawa, Tomoko Nagamine, Kento Goto, Hiroshi Fukuda, Teruhiko Hisaoka, Toshio Naito
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	BMC 2025-02-01
Reeks:	BMC Endocrine Disorders
Onderwerpen:	Pemafibrate Hypertriglyceridemia Type 2 diabetes mellitus Triglyceride Liver function
Online toegang:	https://doi.org/10.1186/s12902-025-01872-w
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!